Merck to develop AnteoBind-activated Europium particle products
BRISBANE: AnteoTech Ltd has signed a non-binding Heads of Agreement with Merck to co-develop AnteoBind activated Europium particles for the rapidly growing global point of care (PoC) diagnostic testing market. The products will harness Merck’s full range of Europium particles…